Step 2 Starting Dose and Titration: Tirzepatide starts at 2.5mg weekly for 4 weeks, then increases by 2.5mg every 4 weeks through 5mg, 7.5mg, 10mg, 12.5mg to the maximum 15mg dose
The active ingredient remains the same, although a compounding pharmacy may add or remove non-essential ingredients
Key Metrics to Track Comprehensive monitoring should include: Body composition changes Weekly weight measurements (same time, same conditions) Monthly body composition analysis (if available) Circumference measurements (waist, hips, thighs) Progress photographs for visual documentation Metabolic markers Fasting glucose levels (if relevant to research goals) Lipid panels at baseline and regular intervals Blood pressure monitoring Resting heart rate trends Subjective responses Appetite and satiety patterns Energy levels throughout the day Sleep quality and duration Mood and cognitive function Gastrointestinal symptom severity and frequency Dosing compliance Injection timing and consistency Missed doses and reasons Site rotation adherence Storage condition maintenance For researchers implementing systematic peptide protocols, these metrics provide essential data for protocol optimization and outcome assessment
Tirzepatide accumulates in your system over weeks, so resume your regular schedule on your next planned injection day without doubling up
What documentation is your provider maintaining to satisfy the 503A "significant difference" or individualized clinical need standard
Gardasil/Gardasil 9 Disease area(s): Vaccines/infectious diseases Manufacturer(s): Merck 2024 Sales (USD): $8.58 billion Why it sold so well: In 2024, Mercks Gardasil/Gardasil 9 vaccine generated $8.58 billion in global sales, marking a 3% decline from the previous year, primarily due to reduced demand in China
